Publication | Closed Access

Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis

Cell-based Drug DeliveryNanomedicineCd44-targeted AlleviationEngineeringBioresponsive MaterialsNano-drug DeliveryWound HealingBiomedical EngineeringUlcerative ColitisDrug Delivery System